Literature DB >> 14736283

Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis.

Pek Yoon Chong, Paul Chui, Ai E Ling, Teri J Franks, Dessmon Y H Tai, Yee Sin Leo, Gregory J L Kaw, Gervais Wansaicheong, Kwai Peng Chan, Lynette Lin Ean Oon, Eng Swee Teo, Kong Bing Tan, Noriko Nakajima, Tetsutaro Sata, William D Travis.   

Abstract

CONTEXT: An outbreak of severe acute respiratory syndrome (SARS), an infectious disease attributed to a novel coronavirus, occurred in Singapore during the first quarter of 2003 and led to 204 patients with diagnosed illnesses and 26 deaths by May 2, 2003. Twenty-one percent of these patients required admission to the medical intensive care unit. During this period, the Center for Forensic Medicine, Health Sciences Authority, Singapore, performed a total of 14 postmortem examinations for probable and suspected SARS. Of these, a total of 8 were later confirmed as SARS infections.
OBJECTIVE: Our series documents the difficulties encountered at autopsy during the initial phases of the SARS epidemic, when the pattern of infection and definitive diagnostic laboratory criteria were yet to be established.
DESIGN: Autopsies were performed by pathologists affiliated with the Center for Forensic Medicine, Health Sciences Authority, Singapore. Tissue was accessed and read at the Tan Tock Seng Hospital, Singapore, and at the Armed Forces Institute of Pathology, Washington, DC. Autopsy tissue was submitted to the Virology Department, Singapore General Hospital, for analysis, and in situ hybridization for the SARS coronavirus was carried out at the National Institute of Infectious Diseases, Tokyo, Japan.
RESULTS: Thirteen of 14 patients showed features of diffuse alveolar damage. In 8 patients, no precipitating etiology was identified, and in all of these patients, we now have laboratory confirmation of coronavirus infection. Two of the 8 patients presented at autopsy as sudden unexpected deaths, while the remaining 6 patients had been hospitalized with varying lengths of stay in the intensive care unit. In 3 patients, including the 2 sudden unexpected deaths, in situ hybridization showed the presence of virally infected cells within the lung. In 4 of the 8 SARS patients, pulmonary thromboemboli were also recognized on gross examination, while one patient had marantic cardiac valvular vegetations.
CONCLUSIONS: It is unfortunate that the term atypical pneumonia has been used in conjunction with SARS. Although nonspecific by itself, the term does not accurately reflect the underlying dangers of viral pneumonia, which may progress rapidly to acute respiratory distress syndrome. We observed that the clinical spectrum of disease as seen in our autopsy series included sudden deaths. This is a worrisome finding that illustrates that viral diseases will have a spectrum of clinical presentations and that the diagnoses made for such patients must incorporate laboratory as well as clinical data.

Entities:  

Mesh:

Year:  2004        PMID: 14736283     DOI: 10.5858/2004-128-195-AODDTS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  115 in total

1.  Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters.

Authors:  Anjeanette Roberts; Leatrice Vogel; Jeannette Guarner; Norman Hayes; Brian Murphy; Sherif Zaki; Kanta Subbarao
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues.

Authors:  Tracey Baas; Jeffery K Taubenberger; Pek Yoon Chong; Paul Chui; Michael G Katze
Journal:  J Interferon Cytokine Res       Date:  2006-05       Impact factor: 2.607

3.  The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells.

Authors:  Yee-Joo Tan; Puay-Yoke Tham; Daphne Z L Chan; Chih-Fong Chou; Shuo Shen; Burtram C Fielding; Timothy H P Tan; Seng Gee Lim; Wanjin Hong
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 4.  The Role of Smoking and Nicotine in the Transmission and Pathogenesis of COVID-19.

Authors:  Ali Ehsan Sifat; Saeideh Nozohouri; Heidi Villalba; Bhuvaneshwar Vaidya; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2020-10-08       Impact factor: 4.030

Review 5.  COVID-19: The Emerging Immunopathological Determinants for Recovery or Death.

Authors:  Tanveer Ahmad; Rituparna Chaudhuri; Mohan C Joshi; Ahmad Almatroudi; Arshad Husain Rahmani; Syed Mansoor Ali
Journal:  Front Microbiol       Date:  2020-12-01       Impact factor: 5.640

6.  Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7a protein is dependent on its interaction with the Bcl-XL protein.

Authors:  Ying-Xim Tan; Timothy H P Tan; Marvin J-R Lee; Puay-Yoke Tham; Vithiagaran Gunalan; Julian Druce; Chris Birch; Mike Catton; Nai Yang Fu; Victor C Yu; Yee-Joo Tan
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

Review 7.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

8.  Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice.

Authors:  Barry Rockx; Timothy Sheahan; Eric Donaldson; Jack Harkema; Amy Sims; Mark Heise; Raymond Pickles; Mark Cameron; David Kelvin; Ralph Baric
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

9.  Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk.

Authors:  Nadine Kabbani; James L Olds
Journal:  Mol Pharmacol       Date:  2020-04-01       Impact factor: 4.436

10.  Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study.

Authors:  Xiao Hou; Li Tian; Lei Zhou; Xinhua Jia; Li Kong; Yitao Xue; Hao Hao; Xianqing Meng; Feihu Zhang; Xiaobin Dong
Journal:  Virol J       Date:  2021-05-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.